(Q42666051)

4 November 2017

title

Plasma pharmacokinetics of two consecutive doses of ferumoxytol in healthy subjects (English)

1 reference

4 November 2017

1 reference

A B Pai

1

1 reference

4 November 2017

J C Nielsen

2

1 reference

4 November 2017

A Kausz

3

1 reference

4 November 2017

P Miller

4

1 reference

4 November 2017

J S Owen

5

1 reference

4 November 2017

language of work or name

English

0 references

publication date

30 June 2010

1 reference

Clinical Pharmacology & Therapeutics

4 November 2017

published in

1 reference

4 November 2017

volume

88

1 reference

4 November 2017

issue

2

1 reference

4 November 2017

page(s)

237-242

1 reference

Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Anemia: an early complication of chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Physicochemical properties of ferumoxytol, a new intravenous iron preparation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Phase I clinical evaluation of a new iron oxide MR contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Labile iron in parenteral iron formulations: a quantitative and comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

Iron storage indices and risk of bacterial infections in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

7 January 2021

A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

7 January 2021

The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

7 January 2021

Iron status in patients receiving erythropoietin for dialysis-associated anemia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

7 January 2021

The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

7 January 2021

Safety of ferumoxytol in patients with anemia and CKD

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

7 January 2021

Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.80

7 January 2021

Identifiers

DOI

10.1038/CLPT.2010.80

1 reference

4 November 2017

1 reference